- Home
- SVRE vs VRAX Comparison
SVRE vs VRAX Comparison
Compare SVRE & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVRE | VRAX |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SVRE | VRAX |
|---|---|---|
| Price | $2.99 | $0.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 120.3K | ★ 162.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $453.30 | $217,274.83 |
| Revenue Next Year | $106.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.20 |
| 52 Week High | $5.69 | $1.85 |
Technical Indicators
Market Signals| Indicator | SVRE | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 83.38 | 39.40 |
| Support Level | $1.99 | $0.20 |
| Resistance Level | $3.11 | $0.52 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 96.20 | 36.94 |
Price Performance
Historical ComparisonAbout SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road and pedestrians. Geographially, it operates in Israel and Europe, out of which it derives maximum revenue from Israel.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.